- Home
- ATRO vs CRMD Comparison
ATRO vs CRMD Comparison
Compare ATRO & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRO
- CRMD
- Stock Information
- Founded
- ATRO 1968
- CRMD 2006
- Country
- ATRO United States
- CRMD United States
- Employees
- ATRO N/A
- CRMD N/A
- Industry
- ATRO Military/Government/Technical
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- ATRO Industrials
- CRMD Health Care
- Exchange
- ATRO Nasdaq
- CRMD Nasdaq
- Market Cap
- ATRO 592.4M
- CRMD 645.0M
- IPO Year
- ATRO N/A
- CRMD 2010
- Fundamental
- Price
- ATRO $20.20
- CRMD $10.13
- Analyst Decision
- ATRO Hold
- CRMD Strong Buy
- Analyst Count
- ATRO 1
- CRMD 6
- Target Price
- ATRO $17.00
- CRMD $15.67
- AVG Volume (30 Days)
- ATRO 270.2K
- CRMD 906.0K
- Earning Date
- ATRO 03-03-2025
- CRMD 03-11-2025
- Dividend Yield
- ATRO N/A
- CRMD N/A
- EPS Growth
- ATRO N/A
- CRMD N/A
- EPS
- ATRO N/A
- CRMD N/A
- Revenue
- ATRO $782,178,000.00
- CRMD $12,262,234.00
- Revenue This Year
- ATRO $15.96
- CRMD N/A
- Revenue Next Year
- ATRO $6.89
- CRMD $234.92
- P/E Ratio
- ATRO N/A
- CRMD N/A
- Revenue Growth
- ATRO 19.95
- CRMD 41184.20
- 52 Week Low
- ATRO $14.13
- CRMD $3.03
- 52 Week High
- ATRO $23.74
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- ATRO 75.80
- CRMD 44.90
- Support Level
- ATRO $18.54
- CRMD $9.79
- Resistance Level
- ATRO $19.03
- CRMD $11.28
- Average True Range (ATR)
- ATRO 0.56
- CRMD 0.51
- MACD
- ATRO 0.07
- CRMD -0.05
- Stochastic Oscillator
- ATRO 97.56
- CRMD 23.84
About ATRO Astronics Corporation
Astronics Corp supplies products to the aerospace, defense, and electronics industries. The company has two reportable segments namely Aerospace and Test Systems. The aerospace segment serves three primary markets: military, commercial transport, and General Aviation. The Test Systems segment serves the aerospace, defense, and semiconductor markets. The company generates a majority of its revenue from the Aerospace segment. Geographically, it generates a majority of its revenue from the United States.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.